Takeda Pharma unveils haemophilia drug Adynovate in India MD Bureau17 May 2022 1:00 PM ISTThe prophylaxis treatment is named Adynovate and is an innovative extended half-life recombinant Factor VIII (rFVIII) treatment, using established...
Novo Nordisk bags CDSCO panel nod to study anti neoplastic drug Concizumab Dr. Divya Colin24 April 2022 12:30 PM ISTNew Delhi: In line with the drug major Novo-Nordisk's proposal for Phase IIIa clinical trial of antineoplastic drug Concizumab, the Subject Expert...
Pfizer secures CDSCO panel nod to study Hemophilia drug Marstacimab Medical Dialogues Team5 Nov 2021 6:13 PM ISTNew Delhi: In a significant development, drug firm Pfizer has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Himachal Pradesh to extend healthcare benefits to 65 lakh people Medical Dialogues Bureau31 Aug 2019 9:05 AM ISTShimla: Himachal Pradesh Government is extending the benefit of healthcare to 65 Lakh people in the state under Himcare, Sahara Yojana, Environment...
Only 15 percent of haemophilia patients diagnosed in India savita thakur thakur19 April 2016 2:37 PM ISTOnly 15 percent of people in India suffering from haemophilia a genetic and life-threatening bleeding disorder  have been identified while the...
